Study: Melanoma increases may be a matter of over-diagnosis

08/5/2005 | Medscape (free registration)

The striking increase in melanoma rates in the U.S. may be more a matter of heightened awareness and diagnostic scrutiny than the disease increasing in the population, according to a new study. In looking at Medicare claims data on patients older than 65 between 1986 and 2001, researchers found the average biopsy rates and melanomas rose, but the regional and distant disease and mortality remained stable, indicating that an over-diagnosis is taking place.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA